Tacalyx
Developer of cancer therapeutics targeting tumor associated carbohydrate antigens (TACAs)
Seedtable Score
25
Startups
3
Funding Rounds
$28.3m
Money raised
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Tacalyx has raised a total of $20.7m in funding over 3 rounds.
Key Insights:
- Tacalyx Seed Round, April 2026: $13m
- Tacalyx Seed round, September 2019: $7.7m
- Tacalyx funding round, September 2019: $7.6m
Tacalyx Seed Round, April 2026
$13m
Tacalyx Seed round, September 2019
$7.7m
Tacalyx funding round, September 2019
$7.6m
Industries
Tacalyx is active in the following industries: